(Q42552799)

2 November 2017

title

Dobutamine-induced ST segment elevation and ventricular fibrillation with nonsignificant coronary artery disease (English)

1 reference

2 November 2017

main subject

ventricular fibrillation

1 reference

Shaheen J

1

1 reference

2 November 2017

Mendzelevski B

series ordinal

2

1 reference

2 November 2017

Tzivoni D

series ordinal

3

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

2 November 2017

published in

American Heart Journal

1 reference

2 November 2017

volume

132

1 reference

2 November 2017

issue

5

1 reference

2 November 2017

page(s)

1058-1060

1 reference

New developments in pharmacologic stress imaging

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990025-3

Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990025-3

Prognostic value of dobutamine echocardiography in patients with high pretest likelihood of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990025-3

Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990025-3

Dobutamine digital echocardiography for detecting coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990025-3

Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990025-3

Comparison of dobutamine stress echocardiography, dipyridamole stress echocardiography and exercise stress testing for diagnosis of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990025-3

Dobutamine-induced ST segment elevation in a patient with angina at rest and critical coronary lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990025-3

Complication of dobutamine stress echocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990025-3

10.1016/S0002-8703(96)90025-3

7 January 2021

Identifiers

DOI

1 reference

2 November 2017

1 reference